Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Subramaniam Website

Sriram Subramaniam, Ph.D.

Portait Photo of Sriram Subramaniam
Laboratory of Cell Biology
Head, Biophysics Section
Senior Investigator
Center for Cancer Research
National Cancer Institute
Building 50, Room 4306
Bethesda, MD 20892-8008
Phone:  
301-594-2062
Fax:  
301-480-3834
E-Mail:  
subramas@mail.nih.gov

Biography

Dr. Sriram Subramaniam obtained his Ph.D. in physical chemistry from Stanford University and carried out postdoctoral work in the departments of chemistry and biology at the Massachusetts Institute of Technology. In 1992, he joined the faculty at the Johns Hopkins University School of Medicine as an assistant professor, and was promoted to associate professor in 1998. He was appointed as Chief of the Biophysics Section in the Laboratory of Biochemistry in 1998, and subsequently Chief of the Biophysics Section in the Laboratory of Cell Biology in 2003. He continues to maintain a visiting faculty appointment with the Johns Hopkins University School of Medicine.

Research

Three-Dimensional Electron Microscopy at Molecular Resolution

For a more detailed description of our research program, please visit our lab's Web site at http://electron.nci.nih.gov and the website of the Living Lab Structural Biology Center at http://www.livinglab.nih.gov.

The long-term mission of our research program is to obtain an integrated, quantitative understanding of cells and viruses at molecular resolution. We take an interdisciplinary approach to this problem by combining novel technologies for three-dimensional (3D) imaging with computational and cell biological tools. Our research efforts are presently focused on three areas: (1) determination of the structure and mechanisms underlying neutralization and cellular entry of HIV, (2) the development of automated, high-throughput workflows for structure determination of small, dynamic molecular complexes, and (3) the development of novel technologies for 3D imaging of cells and tissues, with particular emphasis on methods for understanding and diagnosing structural signatures of signal transduction and disease progression.

This page was last updated on 6/7/2013.